| http://www.w3.org/ns/prov#value | - A method of treating a pregnancy related hypertensive disorder in a subject on or after the 20th week of pregnancy, said method comprising the step of administering to said subject (i) a compound capable of decreasing soluble endoglin expression levels or soluble endoglin biological activity, wherein said compound is an antibody that specifically binds soluble endoglin, or a soluble endoglin antig
|
